慢病毒介导的HRE-VEGF基因转染大鼠骨髓间充质干细胞的实验研究  

Experimental research on lentivirus mediated HRE-VEGF gene transfection to rat mesenchymal stem cells

在线阅读下载全文

作  者:孔烨[1] 徐洪[1] 章剑锋[1] 邬祎程[1] 

机构地区:[1]上海交通大学医学院附属瑞金医院心脏外科,200025

出  处:《国际心血管病杂志》2012年第6期368-371,376,共5页International Journal of Cardiovascular Disease

基  金:上海市科学技术委员会纳米技术专项(1052nm05300)

摘  要:目的:通过慢病毒系统将HRE-VEGF整合基因转染至MSCs细胞,评价该新型MSCs用于缺血性心肌病的治疗的可行性。方法:运用同尾酶法构建9拷贝缺氧反应元件,并构建9HRE-VEGF表达载体。使用慢病毒系统将目的基因9HRE-VEGF转染干细胞建立转基因MSCs,检测其在不同缺氧、复氧时间VEGF的表达。结果:慢病毒系统转染MSCs具有较高的转染效率,成功构建了整合有9HRE-VEGF的新型转基因MSCs,在低氧下表达VEGF,而在常氧状态下VEGF表达关闭。结论:HRE对转导的VEGF基因表达具有调控作用,缺氧状态下VEGF稳定表达,此低氧诱导调控方式将更有利于缺血性心脏疾病的治疗。Objective: To explore the feasibility of regulating VEGF expression activity by combining VEGF gene with hypoxia response element (HRE), and to evaluate the function of transgenetic MSCs transfected by lentivirus mediated HRE-VEGF gene. Methods: Isocaudarner technique was used to construct 9 copy HRE (9HRE), and 9HRE-VEGF expression vector were re- combined, which were then transfected into rat MSCs by pPACKH1- Lentivector Packaging Kit composed by 3 plasmids. Transgenetic MSCs were incubated under different condition of hypoxia of normoxia at different time set. Methods including immunofluorescence, RT-PCR and ELISA were deployed to detected expression level of VEGF proteinum, VEGF-mRNA and VEGF protein, respectively. Results: MSCs were successfully transfected with 9HRE-VEGF gene via lentivirus trasnfection system, which had high transfection efficiency in this process and facilitated the construction of transgenetic MSCs. VEGF-mRNA and VEGF protein were detected in hypoxia group, which were greatly inhibited in the group under re oxygenation, as both expression level of VEGF- mRNA and VEGF protein were significantly higher under hypoxic condition, compared with these under re- oxygenation state. Conclusion: 130 HRE were proved to regulate the expression of VEGF in the current study, as stable expression of VEGF were detected during hypoxia condition, which might be a promising and favorable gene modification method in treating ischemic heart disease.

关 键 词:骨髓间充质干细胞 血管内皮细胞生长因子 缺氧反应元件 基因治疗 

分 类 号:R329[医药卫生—人体解剖和组织胚胎学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象